Blood · 2007 · 190 citations · 25 references
Life SciencesImmunologyPharmacotherapyImmunotherapyInflammationTransplant ImmunologyAcute RejectionAntibody-mediated RejectionGraft RejectionGraft-versus-host DiseaseTransplant RejectionTreatmentGraft Versus Host Disease ModulationGraft-versus-host Disease Pathophysiology
Graft-versus-host disease (GVHD) is a principal cause of morbidity following allogeneic hematopoietic cell transplantation (HCT). Standard therapy for GVHD, high-dose steroids, results in complete responses (CRs) in 35% of patients. Because tumor necrosis factor-alpha (TNFalpha) is an important effector of experimental GVHD, we treated patients with new-onset GVHD with steroids plus the TNFalpha inhibitor etanercept on a previously reported pilot trial (n = 20) and a phase 2 trial (n = 41). We compared their outcomes with those of contemporaneous patients with GVHD (n = 99) whose initial therapy was steroids alone. Groups were similar with respect to age, conditioning, donor, degree of HLA match, and severity of GVHD at onset. Patients treated with etanercept were more likely to achieve CR than were patients treated with steroids alone (69% vs 33%; P < .001). This difference was observed in HCT recipients of both related donors (79% vs 39%; P = .001) and unrelated donors (53% vs 26%; P < .001). Plasma TNFR1 levels, a biomarker for GVHD activity, were elevated at GVHD onset and decreased significantly only in patients with CR. We conclude that etanercept plus steroids as initial therapy for acute GVHD results in a substantial majority of CRs. This trial was referenced at www.clinicaltrials.gov as NCT00141713.
25
A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment
PJ Martin, Gary Schoch, L Fisher et al. · Blood · 1991 · 569 citations · Full text
Life Sciences, Immunology, Surgery +11
Acute graft-versus-host disease does not require alloantigen expression on host epithelium
Takanori Teshima, Rainer Ordemann, Pavan Reddy et al. · Nature Medicine · 2002 · 519 citations
Life Sciences, Immunology, Pathology +15
A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment
PJ Martin, Gary Schoch, L Fisher et al. · Blood · 1990 · 456 citations · Full text
Life Sciences, Immunology, Surgery +11